![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Tyratech (DI/S) | LSE:TYR | London | Ordinary Share | COM SHS USD0.001 (DI / REGS) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 2.95 | 2.70 | 3.20 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMTYR TIDMTYRU
RNS Number : 0901Z
TyraTech, Inc.
04 March 2013
TyraTech, Inc.
(the "Company" or "TyraTech")
United Kingdom Registration of New Insect Repellent Product NO-SKEETO!(TM)
Field Trials Demonstrate Superior Performance Over Current Market Leading Products
TyraTech, Inc. (AIM: TYR and TYRU), a natural life sciences company, is pleased to announce that the Company has been granted permission to sell its new personal insect repellent in the United Kingdom. This means that the product is approved and ready for immediate commercialization in retail channels. NO-SKEETO!(TM) features TyraTech's Nature's Technology(TM) platform which harnesses the power of natural ingredients to deliver best-in-class efficacy and family safety.
Both Laboratory and Field trials have demonstrated that NO-SKEETO!(TM) significantly outperforms 15% DEET for both mosquito and tick repellency. Trials have been carried out using various species of mosquito including those which are known vectors of West Nile Virus, Malaria, Dengue fever, yellow fever and St Louis encephalitis. Tick trials have included species which are vectors for Lyme disease, Rocky Mountain spotted fever and Southern tick associated rash infection (STARI).
The Company has filed for patent protection for its NO-SKEETO!(TM) formulation and has submitted data from the laboratory and field trials for publication in two international journals. The Company has already been granted registration for NO-SKEETO!(TM) in the U.S. and German markets.
David Paton, TyraTech's Head of European Operations, said "NO-SKEETO!(TM) provides an effective and timely solution for families seeking superior protection without concerns over safety. Our portfolio of European registrations is expected to continue to grow in the coming months. We are currently in the process of evaluating commercial and retail partners for this product and for our other products."
Further information on NO-SKEETO!(TM) is available on the Company's website at www.tyratech.com/RepellentTechnologyOverview
###
For further information please contact:
TyraTech Inc.
Alan Reade, Executive Chairman
Tel: +1 919 415 4310
Bruno Jactel, Chief Executive Officer
Tel: +1 919 415 4280
N+1 Singer, Nominated Adviser and Joint Broker
Aubrey Powell / Alex Wright
Tel: +44 20 7496 3000
First Columbus LLP, Joint Broker
Chris Crawford
Tel: +44 20 3002 2070
Walbrook, Financial PR and IR
Bob Huxford/ Helen Westaway
Tel + 44 20 7933 8792
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCZMGGFFMMGFZZ
1 Year Tyratech Chart |
1 Month Tyratech Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions